On Monday, Shares of Chesapeake Energy Corporation (NYSE:CHK), gained 1.09% to $8.37, hitting its lowest level.
Chesapeake Energy Corporation declared an updated financial strategy. Highlights comprise:
- Elimination of common stock dividend effective 2015 third quarter
- Sale of CHK Cleveland Tonkawa, L.L.C. properties and adjacent assets anticipated to close in 2015 third quarter; redemption of preferred shares in CHK Cleveland Tonkawa partner
- Declaration of preferred stock dividends
Due to the current commodity price environment for oil, natural gas and natural gas liquids, and the resulting reduction in capital accessible to invest in its high-quality assets, Chesapeake Energy will eliminate its common dividend effective 2015 third quarter and redirect the cash into its 2016 capital program to maximize the return accessible to its shareholders.
Chesapeake Energy Corporation produces oil and natural gas through acquisition, exploration, and development of from underground reservoirs in the United States. It holds interests in natural gas resource plays, counting the Haynesville/Bossier Shales in northwestern Louisiana and East Texas.
Shares of Johnson & Johnson (NYSE:JNJ), declined -0.88% to $98.28, during its last trading session.
Johnson & Johnson declared sales of $17.8 billion for the second quarter of 2015, a decrease of 8.8% as contrast to the second quarter of 2014. Operational results reduced 0.9% and the negative impact of currency was 7.9%. Domestic sales reduced 2.4%. International sales reduced 14.3%, reflecting operational growth of 0.5% and a negative currency impact of 14.8%. Not taking into account the net impact of acquisitions and divestitures, on an operational basis, worldwide sales raised 1.7%, domestic sales raised 0.6% and international sales raised 2.7%. * Additionally not taking into account hepatitis C sales, underlying operational growth worldwide was 5%. *
The Company raised its adjusted earnings guidance for full-year 2015 to $6.10 - $6.20 per share. The Company’s guidance excludes the impact of after-tax intangible amortization expense and special items.
Positive contributors to Consumer operational results were sales of over-the-counter products counting ZYRTEC ® allergy medications and TYLENOL ® analgesics; international feminine protection products; and LISTERINE ® oral care products.
Johnson & Johnson, together with its auxiliaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices.
Finally, Genworth Financial, Inc. (NYSE:GNW), ended its last trade with -2.62% loss, and closed at $7.05.
Genworth Financial declared it will issue its earnings release and financial supplement containing the second quarter results after the market closes on August 4. A conference call will be held the following day, August 5, at 10:00 AM (ET) to talk about the results for the quarter.
Genworth Financial, Inc. provides insurance, retirement, and homeownership solutions in the United States and internationally. It operates through U.S. Life Insurance, International Mortgage Insurance, U.S. Mortgage Insurance, International Protection, and Runoff segments.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.